We hypothesized that (1) compared to GH alone, treatment with GH plus PIO would result in better short-term glucose metabolism; and (2) compared to placebo, treatment with GH plus PIO would lead to greater reductions in both VAT and insulin resistance over time. This evidence concerns the gene GH1 and Insulin resistance.